Chemotherapy: topoisomerases as targets.
D002166:Camptothecin / Q000627:therapeutic use; D002460:Cell Line; D002470:Cell Survival; D004264:DNA Topoisomerases, Type I / Q000378:metabolism / Q000502:physiology*; D004250:DNA Topoisomerases, Type II / Q000378:metabolism / Q000502:physiology*; D004273:DNA, Neoplasm / Q000187:drug effects*; D005544:Forecasting; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics
D004273:DNA, Neoplasm; D004264:DNA Topoisomerases, Type I; D004250:DNA Topoisomerases, Type II; D002166:Camptothecin